Gregory Horvath Email & Phone Number

New York, New York, Us

• Monitor performance of the supply chain for the Women’s Health, Lung Oncology, Biosimilar, and I&I brands (totaling $3.6B in annual gross revenue)• Update various systems such as SAP with accurate demand plans ensuring continuous, adequate levels of inventory while achieving pre-determined financial and forecast error / bias targets and minimizing inventory write-off• Communicate information pertaining to demand issues, impacts to supply, mitigation plans, etc. to various organizations, including the commercial Business Unit, the AMP team, and logistics• Generate and coordinate the market level S&OP meeting ensuring alignment between multiple organizations with respect to demand, supply, process change management, and inventory risk• Lead the launch and subsequent monitoring post-launch of new products (including the simultaneous launch of three biosimilar brands in one quarter) with an emphasis on multiple varying demand scenarios utilizing the assistance of cross functional teams from across the network• Create a digitized “one stop shop” for brand / BU metrics regarding FE, FB, % in stock, and MOH in Tableau with the assistance of counterparts in the CA Supply Chain and AMP, allowing for the ease of preparation, consistent standardization, and the capability to quickly adapt to market, BU, brand, or SKU• Contribute to the roll out, deliverables, and implementation of the New Product Launch Optimization Team, including work on the long-range planning consensus meeting, top down forecasting, potential changes to the AFW process, and a budget process that will afford accurately determined year end inventory

New York, New York, Us

• Understood, developed and aligned the supply chain product strategy to support US commercialization while satisfying regional, quality, and regulatory requirements• Led cross-functional launch teams (including commercial, R&D, marketing, and the AMP Hub) to ensure proper product set-up in our systems and alignment with both the physical and financial flow requirements• Updated and maintained a master database for assigned molecules with visibility to product launch dates, submission dates, revenue, regional mfg. / pkg. / labeling information, distribution strategy, financial information, demand, etc.• Developed a “launch playbook” outlining the processes, documents, interfaces, and challenges associated with each step of a New Product Launch and adapted these processes to the Private Label launch process• Oversaw, prepared, and reported metrics for ORM’s and S&OP Meetings regarding launch status, risks, opportunities, and revenue on a monthly basis as well as changes to projects on a weekly basis • Ensured a smooth transition of commercial product supply to the demand planning group

Parsippany, Nj, Us

• Acted as core team member of the SAP deployment team, working with various regions, markets, and functions supporting blueprinting, gap analysis, design, data cleansing, user acceptance testing, training, and hyper care• Authored decision documents, process flows and SOP’s• Lead post go-live initiatives such as management of purchase orders through a contracting process and global alignment of purchasing groups for assistance in identifying end users on behalf of accounts payable

Parsippany, Nj, Us

• Assumed responsibility for end-to-end supply chain activities related to my respective API’s, including Oclacitinib Maleate, which is used to produce Apoquel, the first product launched by Zoetis• Communicated with global partners both internal (COQA, Key Brands, External Supply, etc.) and external (both API and DP CMO’s) to Zoetis to ensure proper forecasts and demand are identified and sustained, to optimize inventory levels of major brands, and to minimize impact to supply• Performed regular inventory analysis (including inventory reconciliation and distressed inventory activities at contract manufacturer’s) to ensure maintenance of safety stock for my key/major API’s using a statistical formula to ensure no stock outs occurred• Constructed working capital forecasts and ensure timely submission of annual volumes for budget analysis• Resolved day-to-day issues regarding erroneous invoices, incorrect transfer prices, etc. and support initiatives to achieve positive PPV when possible• Managed temporary import bonds and act as the Importer of Record for API materials being shipped to contract manufacturer’s within the US ensuring timely release of product by customs and the FDA while realizing savings by transitioning transportation methods and by working in conjunction with trade compliance in order to recover spent duties through the duty drawback process

New York, New York, Us

New York, New York, Us

New York, New York, Us

Analytical Chemistry

Bs, Chemistry